> News > Abionic Successfully Raises CHF 20 Million in Series C Financing
Abionic Successfully Raises CHF 20 Million in Series C Financing
Network of Eminent High Net Worth Individuals Join Financing Syndicate
Financing to Extend Abionic’s Portfolio of Point-of-Care IVD Tests for Critical Care and Emergency Medicine
International Clinical Study of World’s Most Rapid Sepsis Test Starts in 14 Hospitals
Biopôle, Lausanne, Switzerland, March 28, 2018 – Abionic SA, a developer of disruptive nanotechnology based rapid diagnostic solutions, announced today the successful closing of a CHF 20 million Series C financing. The round was led by Pierangelo Bottinelli, Chairman of Symphony International Holdings Limited, and included Philippe Glatz (Chairman of two private hospitals), Peter Brabeck-Letmathe (former CEO and Chairman of Nestlé), Arkady Volozh (Co-Founder and CEO of Yandex), Jean-Bernard and Nelson Dumas (Owners of Dumas Construction), Investiere AG and Zürcher Kantonalbank.